Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Sales | 587 | 711 | 473 | 510 | 673 |
| Cost of Goods | 150 | -550 | 180 | 180 | 190 |
| Gross Profit | 430 | 540 | 290 | 320 | 470 |
| Operating Expenses | 1,330 | -620 | 680 | 1,500 | -1,180 |
| Operating Income | -743 | 1,331 | -207 | -990 | 1,853 |
| Interest Expense | 0 | -5 | 8 | 3 | 0 |
| Other Income | -17 | -566 | 655 | -247 | -2,953 |
| Pre-tax Income | -760 | 770 | 440 | -1,240 | -1,100 |
| Net Income Continuous | -761 | -2,387 | 549 | -1,003 | -821 |
| Net Income | $-761 | $-2,387 | $549 | $-1,003 | $-821 |
| EPS Basic Total Ops | -1.20 | -1.60 | 0.80 | -1.60 | -1.60 |
| EPS Basic Continuous Ops | -1.33 | -4.27 | 0.80 | -1.60 | -1.60 |
| EPS Diluted Total Ops | -1.20 | -1.60 | 0.80 | -1.60 | -1.60 |
| EPS Diluted Continuous Ops | -1.33 | -4.27 | 0.80 | -1.60 | -1.60 |
| EBITDA(a) | $-743 | $3,143 | $-127 | $-910 | $1,923 |